Protagonist Therapeutics Inc buy BMO Capital Markets
Start price
06.12.24
/
50%
€50.50
Target price
06.12.25
€58.44
Performance (%)
62.38%
End price
07.12.25
€82.00
Summary
This prediction ended on 07.12.25 with a price of €82.00. The BUY prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc saw massive gains of 62.38%. BMO_Capital_Markets has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 11.429% | 11.429% | 257.798% |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $62.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
11.03.25
11.03.25
€66.33
11.03.26
11.03.26
54.46%
27.02.26
27.02.26
Stopped prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€75.50
13.10.25
13.10.25
-
13.10.26
13.10.26
3.31%
27.02.26
27.02.26